Genetic Determinants of Circulating Adiponectin Levels, a Complex Multifactorial Intermediate Phenotype
- 1Genetics Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureş, 540142 Târgu Mureş, Romania
Abstract
Circulating adiponectin represents a complex trait with a multifactorial background influenced by internal and external genetic and non-genetic factors, as well as physiological and pathological conditions. It is an important intermediate phenotype characterized by unusually high levels, paradoxical associations with obesity or mortality, and analytical difficulties. Family studies, genome-wide linkage and association analyses demonstrate genetics as a major determinant, though possibly of lesser importance than in similar traits. Heritability values estimated by classical family studies vary significantly (30–93%), depending on study design, age, sex and ancestry. The strongest signals characterized by population differences are on chromosome 3 and 16, where ADIPOQ and CDH13 encoding adiponectin and T-cadherin reside, but tens of other loci situated on almost all chromosomes and genetic variants related to over 150 genes are suspected to modulate plasma levels, frequently by unexplained mechanisms. Population-specific high-impact rare missense mutations (e.g., G45R, R55C, G84R, G90S, R112C, I164T) and common synonymous exon (rs2241766), intron (e.g., rs1501299, rs17366568) or regulatory sequence (e.g., rs17300539, rs266729, rs6773957) variants of ADIPOQ, often in linkage disequilibrium, affect circulating adiponectin levels, usually by altering multimer assembly or gene expression regulation. Three decades of adiponectin genetics research contributed significantly to deciphering adiponectin biology, and emerging genomic technologies may clarify current knowledge gaps.
Related
- Circulating low- and medium-molecular-weight adiponectin are associated with metabolic phenotypes in adults undergoing cardiometabolic screening
- Establishment and characterization of LNCaP-TR-BoM, a bone metastasis-derived prostate cancer cell line with an intermediate AR-attenuated phenotype
- A Measurable Systemic Immune Phenotype Links Circulating Myeloid Dysfunction to Tumour Spatial Organization in Gastroesophageal Adenocarcinoma
- CIRCULATING INFLAMMATORY MEDIATORS REPROGRAM PLATELETS TOWARD A PRO-COAGULANT PHENOTYPE IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
- Associations of TNF-α, Uric Acid, and the Leptin/Adiponectin Ratio with HOMA-IR in Hospitalized Adults: A Cross-Sectional Secondary Analysis of 147 Patients
BibTeX
@article{csep2026genetic,
title = {{Genetic Determinants of Circulating Adiponectin Levels, a Complex Multifactorial Intermediate Phenotype}},
author = {Katalin Csép},
journal = {Biomolecules},
year = {2026},
month = oct,
doi = {10.3390/biom16101474},
url = {https://www.mdpi.com/2218-273X/16/10/1474},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Genetic Determinants of Circulating Adiponectin Levels, a Complex Multifactorial Intermediate Phenotype
AU - Katalin Csép
PY - 2026
DA - 2026/10/10
JO - Biomolecules
DO - 10.3390/biom16101474
UR - https://www.mdpi.com/2218-273X/16/10/1474
AB - Circulating adiponectin represents a complex trait with a multifactorial background influenced by internal and external genetic and non-genetic factors, as well as physiological and pathological conditions. It is an important intermediate phenotype characterized by unusually high levels, paradoxical associations with obesity or mortality, and analytical difficulties. Family studies, genome-wide linkage and association analyses demonstrate genetics as a major determinant, though possibly of lesser importance than in similar traits. Heritability values estimated by classical family studies vary significantly (30–93%), depending on study design, age, sex and ancestry. The strongest signals characterized by population differences are on chromosome 3 and 16, where ADIPOQ and CDH13 encoding adiponectin and T-cadherin reside, but tens of other loci situated on almost all chromosomes and genetic variants related to over 150 genes are suspected to modulate plasma levels, frequently by unexplained mechanisms. Population-specific high-impact rare missense mutations (e.g., G45R, R55C, G84R, G90S, R112C, I164T) and common synonymous exon (rs2241766), intron (e.g., rs1501299, rs17366568) or regulatory sequence (e.g., rs17300539, rs266729, rs6773957) variants of ADIPOQ, often in linkage disequilibrium, affect circulating adiponectin levels, usually by altering multimer assembly or gene expression regulation. Three decades of adiponectin genetics research contributed significantly to deciphering adiponectin biology, and emerging genomic technologies may clarify current knowledge gaps.
SN - 2218-273X
ER -